1. bookVolumen 57 (2007): Edición 3 (September 2007)
Detalles de la revista
License
Formato
Revista
eISSN
1846-9558
ISSN
1330-0075
Primera edición
28 Feb 2007
Calendario de la edición
4 veces al año
Idiomas
Inglés
Acceso abierto

Development of spray-dried co-precipitate of amorphous celecoxib containing storage and compression stabilizers

Publicado en línea: 18 Sep 2007
Volumen & Edición: Volumen 57 (2007) - Edición 3 (September 2007)
Páginas: 287 - 300
Detalles de la revista
License
Formato
Revista
eISSN
1846-9558
ISSN
1330-0075
Primera edición
28 Feb 2007
Calendario de la edición
4 veces al año
Idiomas
Inglés

A. R. Paradkar, B. Chauhan, S. Yamamura and A. P. Pawar, Preparation and characterization of glassy celecoxib, Drug Dev. Ind. Pharm.29 (2003) 739--744; DOI: 10.1081/DDC-120021773.10.1081/DDC-120021773Search in Google Scholar

P. Gupta, G. Chawala and A. K. Bansal, Physical stability and solubility advantage from amorphous celecoxib: The role of thermodynamic quantities and molecular mobility, Mol. Pharm.1 (2004) 406--413; DOI: 10.1021/mp049938f.10.1021/mp049938fSearch in Google Scholar

M. K. Gupta., A. Vanwert and R. H. Bogner, Formation of physically stable amorphous drugs by milling with Neusilin, J. Pharm. Sci.92 (2003) 536--551; DOI: 10.1002/jps.10308.10.1002/jps.10308Search in Google Scholar

D. Q. Craig, P. G. Royall, V. L. Kett and M. L. Hopton, The relevance of the amorphous state to pharmaceutical dosage forms: glassy drugs and freeze dried systems, Int. J. Pharm.179 (1999) 179--207; DOI: 10.1016/S0378-5173(98)00338-X.10.1016/S0378-5173(98)00338-XSearch in Google Scholar

A. A. Ambike, K. R. Mahadik, A. R. Paradkar, Stability study of amorphous valdecoxib, Int. J. Pharm.282 (2004) 151--162; DOI: 10.1080/03639040500272025.10.1080/03639040500272025Search in Google Scholar

A. Paradkar, M. Maheshwari, R Kamble, I. Grimsey and P. York, Design and evaluation of celecoxib porous particles using melt sonocrystallization, Pharm. Res.23 (2005) 1395--1400; DOI: 10.1007/s11095-006-0020-4.10.1007/s11095-006-0020-4Search in Google Scholar

D. Law, S. L. Krill, E. A. Schmitt, J. J. Fort, Y. H. Qiu, W. L. Wang and W. R. Porter, Physicochemical considerations in the preparation of amorphous ritonavir-poly(ethylene glycol) 8000 solid dispersions, J. Pharm. Sci.90 (2001) 1015--1025; DOI: 10.1002/jps.1054.10.1002/jps.1054Search in Google Scholar

H. Suzuki and H. Sunada, Influence of water-soluble polymers on the dissolution of nifedipine solid dispersions with combined carriers, Chem. Pharm. Bull.46 (1998) 482--487.Search in Google Scholar

S. L. Shimpi, B. Chauhan, K. R. Mahadik and A. R. Paradkar, Stabilization and improved in-vivo performance of amorphous etoricoxib using gelucier 50/13, Pharm. Res.22 (2005) 1727--1734; DOI: 10.1007/s11095-005-6694-1.10.1007/s11095-005-6694-1Search in Google Scholar

P. Gupta, V. K. Kakamanu and A. K. Bansal, Stability and solubility of celecoxib-PVP amorphous dispersions: molecular perspective, Pharm. Res.21 (2004) 1762-1769; DOI:10.1023/B:PHAM. 0000045226.42859.b8.Search in Google Scholar

P. Gupta, R. Thilagavathi, A. K. Chakraborti and A. K. Bansal, Role of molecular interaction in stability of celecoxib-PVP amorphous systems, Mol. Pharm.2 (2005) 384--391.Search in Google Scholar

J. Akbuga, A. Gursoy and F. Yetimoglu, Preparation and properties of tablets prepared from furosemide-PVP solid dispersion systems, Drug Dev. Ind. Pharm.14 (1988) 2091--2108.Search in Google Scholar

K. R. Morris, U. J. Griesserb, C. J. Eckhardt and J. G. Stowell, Theoretical approaches to physical transformations of active pharmaceutical ingredients during manufacturing processes, Adv. Drug Deliv. Rev.48 (2001) 91--114; DOI: 10.1016/S0169-409X(01)00100-4.10.1016/S0169-409X(01)00100-4Search in Google Scholar

T. Matsumoto, N. Kaneniwa, S. Higuchi and M. Otsuka, Effects of temperature and pressure during compression on the polymorphic transformation and crushing strength of chlorpropamide tablets, J. Pharm. Pharmacol.43 (1991) 74--78.Search in Google Scholar

V. Andronis and G. Zografi, The molecular mobility of supercooled amorphous indomethacin as a function of temperature and relative humidity, Pharm. Res.15 (1998) 835--842.Search in Google Scholar

M. Otsuka, M. Nakanishi and Y. Matsuda. Effects of crystalline form on compression mechanism of phenobarbital polymorphs, Drug Dev. Ind. Pharm.25 (1999) 205--215.Search in Google Scholar

C. Lefebvre, A. M. Guyot-Hermann, M. Draguet-Bruchmans and R. Bouche, Polymorphic transitions of carbamazepine during grinding and compression, Drug Dev. Ind. Pharm.12 (1986) 1913--1927.Search in Google Scholar

H. Chan and E. Doelker, Polymorphic transformation of some drugs under compression, Drug Dev. Ind. Pharm.11 (1985) 315--332.10.3109/03639048509056874Search in Google Scholar

A. G. Schmidt, S. Wartewig and K. M. Picker, Potential of carrageenan to protect drugs from polymorphic transformation, Eur. J. Pharm. Biopharm.56 (2003) 101--110; DOI: 10.1016/S0939--6411(03)00037-7.Search in Google Scholar

K. M. Picker, "Soft tableting": A new concept to tablet pressure sensitive materials, Pharm. Dev. Technol.9 (2004) 107--121; DOI: 10.1081/PDT-120027426.10.1081/PDT-120027426Search in Google Scholar

United States Pharmacopoeia 24, National Formulary 19, USP Convention, Rockville 2000.Search in Google Scholar

Artículos recomendados de Trend MD

Planifique su conferencia remota con Sciendo